ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,816 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenRepertoire Immune Medicines (Switzerland) AG
Repertoire Immune Medicines (Switzerland) AG Logo
Verified· 2 sources

Repertoire Immune Medicines (Switzerland) AG

Summary

About the company

The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Industry:
Research & Development
Pharmaceutical Industry
✓ Offered6
DECODE Platform
Suite of integrated experimental and computational technologies for analysing the immunological synapse system, identifying TCRs and disease-relevant epitopes across all human HLAs.
TCR-Bispecific Immune Medicines
Off-the-shelf TCR-bispecifics with a TCR, anti-CD3 module and a tumor-specific epitope; developed for solid and haematological cancers.
mRNA Cancer Vaccines
Off-the-shelf mRNA cancer vaccines with shared, highly immunogenic tumor-specific epitopes in lipid nanoparticles; under development for non-small cell lung cancer and colorectal cancer.
mRNA Tolerizing Vaccines
Off-the-shelf mRNA tolerizing vaccines with disease-relevant, tissue-specific epitopes and an immunomodulator; developed to restore immune homeostasis in autoimmune diseases.
Programmed immunotherapies for cancer
Targeted immune medicines for the treatment of solid and haematological tumours, including several programmed approaches for different cancer types.

Knowledge

No knowledge articles yet

Once Repertoire Immune Medicines (Switzerland) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Repertoire Immune Medicines (Switzerland) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Repertoire Immune Medicines (Switzerland) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Repertoire Immune Medicines (Switzerland) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 27
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-153.467.041
Founded
2018 · 8 years
Last commercial register change
April 17, 2025
Employees
21 to 50

Similar companies

AA
Athebio AG
Schlieren
HA
hemotune AG
Schlieren
ST
Stiftung Technopark Zürich
Zurich
BC
Balgrist Campus AG
Zurich
FP
Fahrländer Partner AG
Zurich
FP
Fahrländer Partner Raumentwicklung AG
Zurich
IA
IOPH AG
Dietikon
SC
Stem Cell Bank of Switzerland GmbH
Zurich